SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-041515
Filing Date
2023-08-11
Accepted
2023-08-10 18:28:58
Documents
6
Effectiveness Date
2023-08-11

Document Format Files

Seq Description Document Type Size
1 S-8 eldn_2023.08_s-8.htm S-8 177487
2 EX-5.1 eldn-ex5_1.htm EX-5.1 9879
3 EX-23.1 eldn-ex23_1.htm EX-23.1 4684
4 EX-24.1 eldn-ex24_1.htm EX-24.1 58761
5 EX-FILING FEES eldn-exfiling_fees.htm EX-FILING FEES 25340
6 GRAPHIC img24513963_0.jpg GRAPHIC 16495
  Complete submission text file 0000950170-23-041515.txt   300233
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273900 | Film No.: 231161023
SIC: 2834 Pharmaceutical Preparations